Multiple Assemblies exist for SMTL entry 3g5n
Triple ligand occupancy crystal structure of cytochrome P450 2B4 in complex with the inhibitor 1-biphenyl-4-methyl-1H-imidazole; X-RAY DIFFRACTION 2.50 Å

SMTL ID
3g5n.1
Ligands
PROTOPORPHYRIN IX CONTAINING FE; 1-(BIPHENYL-4-YLMETHYL)-1H-IMIDAZOLE; 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE
Polypeptides
Cytochrome P450 2B4
Oligo-state
homo-tetramer
SMTL ID
3g5n.2
Ligands
PROTOPORPHYRIN IX CONTAINING FE; 1-(BIPHENYL-4-YLMETHYL)-1H-IMIDAZOLE; 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE
Polypeptides
Cytochrome P450 2B4
Oligo-state
monomer
SMTL ID
3g5n.3
Ligands
1-(BIPHENYL-4-YLMETHYL)-1H-IMIDAZOLE; PROTOPORPHYRIN IX CONTAINING FE; 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE
Polypeptides
Cytochrome P450 2B4
Oligo-state
monomer
SMTL ID
3g5n.4
Ligands
PROTOPORPHYRIN IX CONTAINING FE; 1-(BIPHENYL-4-YLMETHYL)-1H-IMIDAZOLE; 5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE
Polypeptides
Cytochrome P450 2B4
Oligo-state
monomer
SMTL ID
3g5n.5
Ligands
5-CYCLOHEXYL-1-PENTYL-BETA-D-MALTOSIDE; PROTOPORPHYRIN IX CONTAINING FE; 1-(BIPHENYL-4-YLMETHYL)-1H-IMIDAZOLE
Polypeptides
Cytochrome P450 2B4
Oligo-state
monomer